Vera Therapeutics stock rose on FDA acceptance of atacicept BLA for priority review in IgAN, a potential multi-billion dollar ...
Vera Therapeutics received priority review from the FDA for its biologics license application for atacicept to treat adults ...
The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.
In patients who undergo lower limb orthopedic surgery, the use of single-shot femoral nerve block is associated with an ...
Atacicept is a recombinant fusion protein that binds to and inhibits the activity of BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback